ADD / ADHD Medication

Health Canada Issued a news release late last month with the title “New Information Regarding Uncommon Psychiatric Adverse Events For All ADHD Drugs” Here’s their first paragraph from their release OTTAWA – Health Canada is informing Canadians that the prescribing and patient information for all drugs used for the management […]

Health Canada Rings ADHD Medication Alarm, Media Respond … But ...

Update: CADDRA has suddenly changed the website address of the ADHD Practice Guidelines. The new one is at Here’s a complete answer to the above complaint I hear and read far, far too often all over North America. The CADDRA (Canadian ADD Resource Alliance) Canadian ADHD Practice Guidelines 2006. […]

Complete Solutions For The “Help, My Doctor, Psychologist, Psychiatrist Doesn’t ...

Update: They shut down the BC Adult ADHD clinic and abandoned the patients. No other hospital has opened a similar clinic to deal with the needs of Adults with ADHD. There’s a one year wait to get diagnosed at the main place that does it in Vancouver, the ADHD clinic […]

1 Year Wait To Get Diagnosed At Vancouver’s BC Adult ...

It’s no secret to those who understand Attention Deficit Hyperactivity Disorder that many people who work in the media have ADHD. The fast paced, constantly new, multitasking, creative, stimulating environment is a natural fit for them. The adrenaline fuelled deadlines that help them focus are also a bonus. You won’t […]

9 Advantages of having ADHD as a Radio Talk Show ...

The percentage of attention deficit hyperactivity disorder children in the US who have been taking stimulant medication between 1997 and 2002 hasn’t changed, according to data collected by the federal government and summarized in the April 2006 issue of The American Journal of Psychiatry. It was a representative national survey […]

Sky NOT Falling! Percentage of Children Taking ADHD Stimulant Medications ...

See Also Part 1 Federal health advisers said Wednesday that Ritalin and other drugs for attention deficit hyperactivity disorder should not carry strong ”black-box” warnings about potential cardiovascular and psychiatric risks. Rather, the Food and Drug Administration pediatric advisory committee recommended that the drug labels include warning language written so […]

FDA and ADHD Stimulant Medication. Science or Stigma? Part 2